Sana Biotechnology (SANA) Prepaid Assets (2020 - 2026)
Sana Biotechnology recorded quarterly Prepaid Assets of $6.4 million in Q1 2026, up 4.26% quarter-over-quarter from $6.1 million in Q4 2025, and up 65.81% year-over-year from $3.8 million in Q1 2025.
Sana Biotechnology's Prepaid Assets history runs 7 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 65.81% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $6.4 million (up 65.81% YoY), while the FY2025 annual figure was $6.1 million, up 36.17% from the prior year.
- Prepaid Assets came in at $6.4 million for Q1 2026 at Sana Biotechnology, up from $6.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $14.5 million in Q1 2023 to a low of $3.8 million in Q1 2025.
- A 5-year average of $7.6 million and a median of $6.6 million in 2023 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 102.31% in 2022 and tumbled 68.78% in 2023, its largest moves.
- Sana Biotechnology's Prepaid Assets stood at $14.4 million in 2022, then sank by 68.78% to $4.5 million in 2023, then declined by 0.2% to $4.5 million in 2024, then soared by 36.17% to $6.1 million in 2025, then grew by 4.26% to $6.4 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $6.4 million, $6.1 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 4.51 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Mar 31, 2025 | 3.84 Mn |
| Dec 31, 2024 | 4.48 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 7.98 Mn |
| Mar 31, 2024 | 6.35 Mn |
| Dec 31, 2023 | 4.49 Mn |
| Sep 30, 2023 | 7.12 Mn |
| Jun 30, 2023 | 6.61 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 14.37 Mn |
| Sep 30, 2022 | 8.40 Mn |
| Jun 30, 2022 | 9.61 Mn |
| Mar 31, 2022 | 10.84 Mn |
| Dec 31, 2021 | 7.11 Mn |
| Sep 30, 2021 | 9.13 Mn |
| Jun 30, 2021 | 7.50 Mn |
| Mar 31, 2021 | 7.24 Mn |
| Dec 31, 2020 | 6.20 Mn |